144 related articles for article (PubMed ID: 34009005)
1. Lot-to-lot reproducibility, stability and life cycle management of antibody reagents for flow cytometry.
Lanham DF
Bioanalysis; 2021 May; 13(10):745-759. PubMed ID: 34009005
[TBL] [Abstract][Full Text] [Related]
2. 2019 White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation (Part 3 - Recommendations on 2019 FDA Immunogenicity Guidance, Gene Therapy Bioanalytical Challenges, Strategies for Critical Reagent Management, Biomarker Assay Validation, Flow Cytometry Validation & CLSI H62).
Piccoli S; Mehta D; Vitaliti A; Allinson J; Amur S; Eck S; Green C; Hedrick M; Hopper S; Ji A; Joyce A; Litwin V; Maher K; Mathews J; Peng K; Safavi A; Wang YM; Zhang Y; Amaravadi L; Palackal N; Thankamony S; Beaver C; Bame E; Emrich T; Grimaldi C; Haulenbeek J; Joyce A; Kakkanaiah V; Lanham D; Maher K; Mayer A; Trampont PC; Vermet L; Dakappagari N; Fleener C; Garofolo F; Rogers C; Tangri S; Xu Y; Liang M; Rajadhyaksha M; Richards S; Schweighardt B; Purushothama S; Baltrukonis D; Brumm J; Cherry E; Delcarpini J; Gleason C; Kirshner S; Kubiak R; Pan L; Partridge M; Pedras-Vasconcelos J; Qu Q; Skibeli V; Saunders TS; Staack RF; Stubenrauch K; Torri A; Verthelyi D; Yan H; Gorovits B; Palmer R; Milton M; Long B; Corsaro B; Farrokhi V; Fiscella M; Henderson N; Jawa V; McNally J; Murphy R; Waldner H; Yang TY
Bioanalysis; 2019 Dec; 11(24):2207-2244. PubMed ID: 31820675
[TBL] [Abstract][Full Text] [Related]
3. Critical reagents in flow cytometry, instrumentation and application in drug discovery development.
Kakkanaiah VN; Matys K; Bennett P
Bioanalysis; 2021 May; 13(10):841-846. PubMed ID: 33890498
[TBL] [Abstract][Full Text] [Related]
4. Immunophenotyping Using Dried and Lyophilized Reagents.
Langweiler M
Methods Mol Biol; 2019; 2032():69-79. PubMed ID: 31522413
[TBL] [Abstract][Full Text] [Related]
5. Ligand binding assay critical reagents and their stability: recommendations and best practices from the Global Bioanalysis Consortium Harmonization Team.
King LE; Farley E; Imazato M; Keefe J; Khan M; Ma M; Pihl KS; Sriraman P
AAPS J; 2014 May; 16(3):504-15. PubMed ID: 24687208
[TBL] [Abstract][Full Text] [Related]
6. Relevance of Antibody Validation for Flow Cytometry.
Kalina T; Lundsten K; Engel P
Cytometry A; 2020 Feb; 97(2):126-136. PubMed ID: 31577065
[TBL] [Abstract][Full Text] [Related]
7. 12th GCC Closed Forum: critical reagents; oligonucleotides; CoA; method transfer; HRMS; flow cytometry; regulatory findings; stability and immunogenicity.
Briscoe C; Hughes N; Hayes R; Islam R; Bennett P; Stouffer B; Cape S; Rhyne P; Beaver C; Charles JS; Kakkanaiah V; Xu A; Caturla MC; Spriggs F; Tayyem R; Barry C; Keyhani A; Zimmer J; Couerbe P; Warren M; Khadang A; Bourdage J; Lindley K; Williams D; Sheldon C; Satterwhite C; Vija J; Yu M; Boulay I; Stamatopoulos J; Lin J; Estdale S; Thomas E; Dinan A; MacNeill R; Xiao YQ; Matassa L; Garofolo W; Savoie N; Hristopoulos G; Xu A; Goodwin L; Awaiye K; Ritzén H; Bouhajib M; Marco CD; Savu SR; Nehls C; Tabler E; Hays A; Karnik S; Brown M; Lowes S; DuBey I; Kulagina N; Lindsay J; Williard C; Wang H; Malone M; Wells E; Fang X; Moussallie M
Bioanalysis; 2019 Jun; 11(12):1129-1138. PubMed ID: 31319683
[TBL] [Abstract][Full Text] [Related]
8. Adventures in critical reagent lot changes in ligand-binding assays: redevelopment, bridging and additional processing requirements.
Rauwerdink A; Benson M; Jayne A; Babu S; St Charles J; Smith A
Bioanalysis; 2021 May; 13(10):771-777. PubMed ID: 33884890
[No Abstract] [Full Text] [Related]
9. Lot-to-lot stability of antibody reagents for flow cytometry.
Böttcher S; van der Velden VHJ; Villamor N; Ritgen M; Flores-Montero J; Escobar HM; Kalina T; Brüggemann M; Grigore G; Martin-Ayuso M; Lecrevisse Q; Pedreira CE; van Dongen JJM; Orfao A
J Immunol Methods; 2019 Dec; 475():112294. PubMed ID: 28365329
[TBL] [Abstract][Full Text] [Related]
10. The impact of ligand binding based assays critical reagent characterization and storage.
Haulenbeek J; Beaver CJ
Bioanalysis; 2021 May; 13(10):797-805. PubMed ID: 34002637
[TBL] [Abstract][Full Text] [Related]
11. Critical reagents issues & solutions for anti-drug antibody assays.
Vermet L
Bioanalysis; 2021 May; 13(10):779-786. PubMed ID: 33884895
[No Abstract] [Full Text] [Related]
12. Visualization of multiprotein complexes by flow cytometry.
Schrum AG
Curr Protoc Immunol; 2009 Nov; Chapter 5():5.9.1-5.9.14. PubMed ID: 19918948
[TBL] [Abstract][Full Text] [Related]
13. Critical ligand binding reagent preparation/selection: when specificity depends on reagents.
Rup B; O'Hara D
AAPS J; 2007 May; 9(2):E148-55. PubMed ID: 17614357
[TBL] [Abstract][Full Text] [Related]
14. Stability measurements of antibodies stored on paper.
Wu G; Srivastava J; Zaman MH
Anal Biochem; 2014 Mar; 449():147-54. PubMed ID: 24361717
[TBL] [Abstract][Full Text] [Related]
15. Current and effective strategies for critical reagent characterization, storage, stability, retesting and life cycle management for ligand-binding assays and flow cytometry.
Amaravadi L; Palackal N; Garofolo F
Bioanalysis; 2021 May; 13(10):737-740. PubMed ID: 34037426
[No Abstract] [Full Text] [Related]
16. EBF recommendation on practical management of critical reagents for PK ligand-binding assays.
Pihl S; van der Strate BW; Golob M; Vermet L; Jaitner B; Goodman J; Fjording MS; Timmerman P
Bioanalysis; 2018 Oct; 10(19):1557-1565. PubMed ID: 30226086
[TBL] [Abstract][Full Text] [Related]
17. Receptor occupancy assessment by flow cytometry as a pharmacodynamic biomarker in biopharmaceutical development.
Liang M; Schwickart M; Schneider AK; Vainshtein I; Del Nagro C; Standifer N; Roskos LK
Cytometry B Clin Cytom; 2016 Mar; 90(2):117-27. PubMed ID: 26054054
[TBL] [Abstract][Full Text] [Related]
18. Validation of a flow cytometry based chemokine internalization assay for use in evaluating the pharmacodynamic response to a receptor antagonist.
Wyant T; Lackey A; Green M
J Transl Med; 2008 Dec; 6():76. PubMed ID: 19046455
[TBL] [Abstract][Full Text] [Related]
19. EBF recommendation on practical management of critical reagents for antidrug antibody ligand-binding assays.
Pihl S; van der Strate BW; Golob M; Ryding J; Vermet L; Jaitner B; Goodman J; Timmerman P
Bioanalysis; 2019 Oct; 11(19):1787-1798. PubMed ID: 31657235
[TBL] [Abstract][Full Text] [Related]
20. Recommendations for the validation of flow cytometric testing during drug development: II assays.
O'Hara DM; Xu Y; Liang Z; Reddy MP; Wu DY; Litwin V
J Immunol Methods; 2011 Jan; 363(2):120-34. PubMed ID: 20946898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
